logo-loader
viewSkinBioTherapeutics PLC

SkinBioTherapeutics - Notice of AGM

RNS Number : 6718U
SkinBioTherapeutics PLC
26 November 2019
 

SkinBioTherapeutics plc

 

Notice of AGM

Manchester, UK - 26 November 2019 - SkinBioTherapeutics plc (AIM: SBTX) a life sciences company focused on skin health, announces its Annual General Meeting will be held on 19 December 2019 at 11am at Centurion House, 129 Deansgate, Manchester, M3 3WR.

A copy of the notice of AGM will be available on the Company's website today.

 

For more information, please contact:

 

SkinBioTherapeutics plc

Stuart Ashman, CEO

Doug Quinn, CFO

 

Tel: +44 (0) 161 468 2760

Cairn Financial Advisers LLP (Nominated Adviser)

Tony Rawlinson / Sandy Jamieson

 

Tel: +44 (0) 20 7213 0880

SP Angel Corporate Finance (Joint Broker)

Vadim Alexandre / Abigail Wayne

 

Tel: +44 (0) 20 3470 0470

 

Turner Pope Investments (Joint Broker)

Andy Thacker / Zoe Alexander

 

 

Tel: +44 (0) 20 3657 0050

 

Instinctif Partners

Melanie Toyne-Sewell / Phil Marriage / Nathan Billis

 

Tel: +44 (0) 20 7457 2020

   [email protected]

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NOACKADQFBDKFDB

Quick facts: SkinBioTherapeutics PLC

Price: 26.3

Market: AIM
Market Cap: £33.69 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

SkinBioTherapeutics CEO hails 'significant scientific milestone' with...

SkinBioTherapeutics PLC's (LON:SBTX) CEO Stuart Ashman speaks to Proactive's Andrew Scott soon after updating investors on the progress of its cosmetic skincare programme and plans for a psoriasis food supplement trial. Sederma, its partner in the cosmetics programme and a division of Croda...

1 week, 3 days ago